Literature DB >> 30044685

Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer.

Addie Hill1, Jun Gong1, Sharon Wilczynski1, Rizvan Mirza1, Loretta Erhunmwunsee1, Ravi Salgia1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30044685     DOI: 10.1200/JOP.18.00127

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  2 in total

1.  Case Report: Pathologic Complete Response to Pembrolizumab in Combination With Neoadjuvant Chemotherapy in a Patient With Stage IIB Squamous Lung Cancer.

Authors:  Lin Zhang; Wuqian Mai; Wenyang Jiang; Qing Geng
Journal:  Front Surg       Date:  2020-11-27

2.  Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma: Case Report and Assessment of Histological Response.

Authors:  Manuel Olmos; Jacek Glajzer; Tjark-Ole Büntemeyer; Gesche Frohwitter; Jutta Ries; Markus Eckstein; Markus Hecht; Rainer Lutz; Marco Rainer Kesting; Manuel Weber
Journal:  Front Oncol       Date:  2021-07-21       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.